5-Hydroxytryptamine (Serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide

Journal of Pharmacology and Experimental Therapeutics

Volumn 320, Issue 2, 2007, Pages 662-669

  Gresch, Paul J ^a   Barrett, Robert J ^b   Sanders Bush, Elaine ^a   Smith, Randy L ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; KETANSERIN; LYSERGIDE; MIANSERIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 2A RECEPTOR; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANNULATION; CINGULATE GYRUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE; TISSUE SECTION;

ANIMALS; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROBENZENES; GYRUS CINGULI; LYSERGIC ACID DIETHYLAMIDE; MALE; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A;

EID: 33846416186     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.112946     Document Type: Article

References (49)

1. Aghajanian GK, Foote WE, and Sheard MH (1968) Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphe. Science (Wash DC) 161:706-708.
2. Aghajanian GK, Foote WE, and Sheard MH (1970) Action of psychotogenic drugs on single midbrain raphe neurons. J Pharmacol Exp Ther 171:178-187.
3. Aghajanian GK, Haigler HJ, and Bloom FE (1972) Lysergic acid diethylamide and serotonin: direct actions on serotonin-containing neurons in rat brain. Life Sci Physiol Pharmacol 11:615-622.
4. Benes FM, Vincent SL, and Todtenkopf M (2001) The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry 50:395-406.
5. Benneyworth MA, Smith RL, Barrett RJ, and Sanders-Bush E (2005) Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice. Psychopharmacology (Berl) 179:854-862.
6. Bouras C, Kovari E, Hof PR, Riederer BM, and Giannakopoulos P (2001) Anterior cingulate cortex pathology in schizophrenia and bipolar disorder. Acta Neuropathol 102:373-379.
7. Brauer LH, Goudie AJ, and de Wit H (1997) Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data. Psychopharmacology (Berl) 130:2-13.
8. Callahan PM and Appel JB (1988) Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline. J Pharmacol Exp Ther 246:866-870.
9. Chana G, Landau S, Beasley C, Everall IP, and Cotter D (2003) Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol Psychiatry 53:1086-1098.
10. Colpaert FC, Meert TF, Niemegeers CJ, and Janssen PA (1985) Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat. Psychopharmacology 86:45-54.
11. Cornea-Hebert V, Riad M, Wu C, Singh SK, and Descarries L (1999) Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol 409:187-209.
12. Cunningham KA and Appel JB (1987) Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD). Psychopharmacology 91:67-73.
13. Devinsky O, Morrell MJ, and Vogt BA (1995) Contributions of anterior cingulate cortex to behaviour. Brain 118:279-306.
14. Doat MM, Rabin RA, and Winter JC (2003) Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD. Pharmacol Biochem Behav 74:713-721.
15. 2C receptors in the stimulus effects of hallucinogenic drugs. III: The mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion. Psychopharmacology (Berl) 121:364-372.
16. 2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis. Psychopharmacology (Berl) 121:347-356.
17. Freedman DX (1961) Effects of LSD-25 on brain serotonin. J Pharmacol Exp Ther 134:160-166.
18. Gabbott PL, Dickie BG, Vaid RR, Headlam AJ, and Bacon SJ (1997) Local-circuit neurones in the medial prefrontal cortex (areas 25, 32 and 24b) in the rat: morphology and quantitative distribution. J Comp Neurol 377:465-499.
19. Gaddum JH and Hameed KA (1954) Drugs which antagonize 5-hydroxytryptamine. Br J Pharmacol Chemother 9:240-248.
20. Glennon RA and Hauck AE (1985) Mechanistic studies on DOM as a discriminative stimulus. Pharmacol Biochem Behav 23:937-941.
21. Glennon RA, Titeler M, and McKenney JD (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35:2505-2511.
22. Gresch PJ, Smith RL, Barrett RJ, and Sanders-Bush E (2005) Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex. Neuropsychopharmacology 30:1693-1702.
23. Gresch PJ, Strickland LV, and Sanders-Bush E (2002) Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors. Neuroscience 114:707-713.
24. Haigler HJ and Aghajanian GK (1973) Mescaline and LSD: direct and indirect effects on serotonin-containing neurons in brain. Eur J Pharmacol 21:53-60.
25. Ismaiel AM, De Los Angeles J, Teitler M, Ingher S, and Glennon RA (1993) Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist. J Med Chem 36:2519-2525.
26. Johanson CE, Kilbey M, Gatchalian K, and Tancer M (2006) Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo. Drug Alcohol Depend 81:27-36.
27. Kamien JB, Bickel WK, Hughes JR, Higgins ST, and Smith BJ (1993) Drug discrimination by humans compared to nonhumans: current status and future directions. Psychopharmacology (Berl) 111:259-270.
28. Meert TF, de Haes P, and Janssen PA (1989) Risperidone (R 64 766), a potent and complete LSD antagonist in drug discrimination by rats. Psychopharmacology (Berl) 97:206-212.
29. Minnema D, Krynock G, Young R, Glennon R, and Rosecrans J (1980) LSD as a discriminative stimulus: role of dorsal raphe nucleus. Subst Alcohol Actions Misuse 1:29-34.
30. Mokler DJ and Rech RH (1984) Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride. Pharmacol Biochem Behav 21:281-287.
31. Nichols DE (2004) Hallucinogens. Pharmacol Ther 101:131-181.
32. Nielsen EB (1985) Discriminative stimulus properties of lysergic acid diethylamide in the monkey. J Pharmacol Exp Ther 234:244-249.
33. Nielsen EB and Scheel-Kruger J (1986) Cueing effects of amphetamine and LSD: elicitation by direct microinjection of the drugs into the nucleus accumbens. Eur J Pharmacol 125:85-92.
34. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates, Academic Press, Inc., New York.
35. Reissig CJ, Eckler JR, Rabin RA, and Winter JC (2005) The 5-HT1A receptor and the stimulus effects of LSD in the rat. Psychopharmacology (Berl) 182:197-204.
36. Schreiber R, Brocco M, and Millan MJ (1994) Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone. Eur J Pharmacol 264:99-102.
37. Schuster CR and Johanson CE (1988) Relationship between the discriminative stimulus properties and subjective effects of drugs. Psychopharmacol Ser 4:161-175.
38. Shergill SS, Brammer MJ, Williams SC, Murray RM, and McGuire PK (2000) Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatry 57:1033-1038.
39. Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S, Seaward J, McKenna P, Chua SE, Schnorr L, et al. (1995) A functional neuroanatomy of hallucinations in schizophrenia. Nature (Lond) 378:176-179.
40. Vogt BA and Miller MW (1983) Cortical connections between rat cingulate cortex and visual, motor, and postsubicular cortices. J Comp Neurol 216:192-210.
41. Vogt BA and Peters A (1981) Form and distribution of neurons in rat cingulate cortex: areas 32, 24, and 29. J Comp Neurol 195:603-625.
42. Vogt BA, Vogt LJ, and Farber NB (2003) Rat cingulate cortex and disease models, in The Rat Nervous System (Paxinos G ed) chapter 22, pp 495-579, Academic Press, Inc., New York.
43. Vollenweider FX, Leenders KL, Scharfetter C, Maguire P, Stadelmann O, and Angst J (1997) Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharmacology 16:357-372.
44. Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Babler A, Vogel H, and Hell D (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9:3897-3902.
45. Walker EA, Yamamoto T, Hollingsworth PJ, Smith CB, and Woods JH (1991) Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon. J Pharmacol Exp Ther 259:772-782.
46. Weiss AP and Heckers S (1999) Neuroimaging of hallucinations: a review of the literature. Psychiatry Res 92:61-74.
47. Winter JC, Eckler JR, and Rabin RA (2004) Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli. Psychopharmacology (Berl) 172:233-240.
48. Winter JC and Rabin RA (1988) Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus. Pharmacol Biochem Behav 30:617-624.
49. Wise RA and Hoffman DC (1992) Localization of drug reward mechanisms by intracranial injections. Synapse 10:247-263.